The Patent Trial & Appeal Board of the US Patent & Trademark Office explained that parties have a duty of candor and good faith before the Board that requires any factual contentions to be well supported by evidence and canceled all challenged claims across five patents
Inter partes reviews (IPRs) are litigation-like procedures held before the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office that are used to.
The Patent Trial & Appeal Board of the US Patent & Trademark Office (PTO) canceled all challenged claims across five patents because the patent owner failed to meet its duty of candor.
In a per curium order issued under seal May 3, 2023 but recently made public, the Patent Trial and Appeal Board awarded sanctions against Patent Owner, Longhorn Vaccines & Diagnostics,.
In DNA Genotek Inc. v. Spectrum Solutions, LLC,[1] DNA Genotek asserted U.S. Patent No. 10,619,187 ("the '187 patent") against Spectrum Solutions ("Spectrum").